Laboratorio Reig Jofre, S.A. (BME:RJF)
2.730
-0.020 (-0.73%)
Aug 7, 2026, 11:27 AM CET
Laboratorio Reig Jofre Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 13.57 | 10.5 | 10.49 | 5.53 | 6.45 | 5.07 |
Short-Term Investments | 1.54 | 6.51 | 13.47 | 0.96 | 0.44 | 2.15 |
Cash & Short-Term Investments | 15.11 | 17.01 | 23.96 | 6.49 | 6.9 | 7.22 |
Cash Growth | -18.74% | -29.01% | 269.14% | -5.92% | -4.42% | -46.96% |
Accounts Receivable | 70.89 | 7.01 | 61.03 | 5.97 | 5.11 | 50.44 |
Inventory | 74.79 | 61.61 | 63.77 | 61.86 | 48.19 | 47.68 |
Other Current Assets | 12.2 | 4.53 | 1.89 | 2.34 | 2.3 | 4.68 |
Total Current Assets | 172.99 | 155.43 | 149.69 | 132.55 | 112.3 | 108.84 |
Net Property, Plant & Equipment | 130.73 | 129.5 | 97.03 | 91.63 | 93.19 | 92.39 |
Other Intangible Assets | 75.4 | 69.58 | 55.29 | 63.07 | 70.89 | 77.73 |
Goodwill | 26.51 | 26.5 | 26.81 | 27.99 | 28.97 | 29.84 |
Long-Term Investments | 1.64 | 1.49 | 6.58 | 6.39 | 5.15 | 3.13 |
Other Long-Term Assets | 13.44 | 12.19 | 9.46 | 8.93 | 10.68 | 13.06 |
Total Assets | 420.7 | 394.69 | 344.85 | 330.55 | 321.19 | 324.98 |
Accounts Payable | 50.19 | 45.78 | 96.85 | 47.74 | 43.97 | 87.75 |
Accrued Expenses | 5.26 | 5.32 | 7.11 | 3.61 | 3.07 | 3.96 |
Short-Term Debt | - | - | 21.44 | - | - | 18.33 |
Current Portion of Long-Term Debt | - | - | 8.41 | - | - | 8.57 |
Current Portion of Leases | 5.07 | 5.74 | - | 4.88 | 5.32 | - |
Unearned Revenue | 1.33 | 2.71 | - | 4.9 | 3.55 | - |
Other Current Liabilities | 0.14 | 0.15 | 0.28 | 0.39 | 0.53 | 2.17 |
Total Current Liabilities | 114.46 | 101.12 | 82.11 | 90.19 | 75.6 | 74.91 |
Long-Term Debt | 110.82 | 90.54 | 42.53 | 48.5 | 51.52 | 55.23 |
Long-Term Leases | 15.39 | 15.33 | - | 9.87 | 11.97 | - |
Other Long-Term Liabilities | 9.02 | 8.68 | 6.27 | 6.4 | 6.72 | 6.32 |
Total Long-Term Liabilities | 82.75 | 73.12 | 48.8 | 36.11 | 51.04 | 61.55 |
Total Liabilities | 197.21 | 174.24 | 130.9 | 126.29 | 126.64 | 136.46 |
Common Stock | 41.44 | 41.11 | 80.9 | 39.82 | 39.21 | 77.43 |
Treasury Stock | -2.86 | -2.84 | -2.86 | -2.83 | -2.82 | -2.4 |
Additional Paid-in Capital | 19.17 | 19.17 | 19.22 | 19.14 | 19.18 | 19.3 |
Accumulated Other Comprehensive Income | -1.9 | -1.28 | -4.59 | -2.09 | -2.49 | -1.85 |
Retained Earnings | 165.25 | 161.9 | 159.46 | 150.31 | 141.55 | 133.91 |
Total Common Shareholders' Equity | 221.11 | 218.07 | 213.97 | 204.35 | 194.63 | 188.59 |
Minority Interest | 2.38 | 2.38 | -0.02 | -0.1 | -0.08 | -0.08 |
Shareholders' Equity | 223.49 | 220.45 | 213.95 | 204.25 | 194.55 | 188.51 |
Total Liabilities & Equity | 420.7 | 394.69 | 344.85 | 330.55 | 321.19 | 324.98 |
Total Debt | 131.28 | 111.61 | 72.38 | 63.25 | 68.81 | 82.13 |
Net Cash (Debt) | -116.17 | -94.6 | -48.43 | -56.76 | -61.91 | -74.91 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -1.43 | -1.16 | -0.60 | -0.71 | -0.79 | -0.96 |
Book Value | 221.11 | 218.07 | 213.97 | 204.35 | 194.63 | 188.59 |
Book Value Per Share | 2.72 | 2.68 | 2.67 | 2.55 | 2.47 | 2.42 |
Tangible Book Value | 119.21 | 122 | 131.87 | 113.3 | 94.77 | 81.02 |
Tangible Book Value Per Share | 1.46 | 1.50 | 1.65 | 1.42 | 1.20 | 1.04 |